Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC)

Published:2014-07 Issue:1 Volume:85 Page:59-65
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Lucas John T.^ORCID,Kuremsky Jeffrey G.,Soike Mike,Hinson William W.,Kearns William T.,Hampton Carnell J.,Blackstock A. William,Urbanic James

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage i lung cancer. A retrospective analysis of patients treated in the Nordic countries;Baumann;Acta Oncol,2006

2. Stereotactic body radiation therapy: the report of AAPM task group 101;Benedict;Med Phys,2010

3. Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904;Bogart;J Clin Oncol,2010

4. A randomized phase iii comparison of standard-dose (60Gy) versus high-dose (74Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: results on radiation dose in RTOG 0617;Bradley,2013

5. Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma;Bradley;Int J Radiat Oncol Biol Phys,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma;Radiotherapy and Oncology;2024-06

2. Optimal Radiation Therapy Fractionation Regimens for Early-Stage Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-09

3. Accelerated hypofractionated radiotherapy with 3 Gy per fraction for central/ultra-central lung tumors: toxicity to mediastinal organs;Japanese Journal of Clinical Oncology;2022-12-06

4. Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution;Cureus;2022-02-03

5. Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2021-05